J. J. Mahany

Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody

Robert H. Vonderheide, Keith T. Flaherty, Magi Khalil et al. · Journal of Clinical Oncology · 2007 · 513 citations

Medicine, Oncology, Pharmacology +16

Phase I Trial of a B7-1 (CD80) Gene Modified Autologous Tumor Cell Vaccine in Combination With Systemic Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma

Scott Antonia, John D. Seigne, José I. Diaz et al. · The Journal of Urology · 2002 · 123 citations

Medicine, Immunology, Oncology +17

Phase II Trial of B7-1 (CD-86) Transduced, Cultured Autologous Tumor Cell Vaccine Plus Subcutaneous Interleukin-2 for Treatment of Stage IV Renal Cell Carcinoma

Mayer Fishman, Terri Hunter, Hatem Soliman et al. · Journal of Immunotherapy · 2008 · 73 citations

Medicine, Immunology, Oncology +17

A phase IB study evaluating BSI-201 in combination with chemotherapy in subjects with advanced solid tumors

J. J. Mahany, N. Lewis, Elisabeth I. Heath et al. · Journal of Clinical Oncology · 2008 · 51 citations

Medicine, Oncology, Pharmacology +13

Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic Study

George R. Simon, Christopher R. Garrett, Stephen C. Olson et al. · Clinical Cancer Research · 2006 · 32 citations · Full text

Pharmacy, Oncology, Pharmacology +12